1. Assigned Priority Review Designation by Secreta
Post# of 3
(Total Views: 64)
Posted On: 01/02/2025 8:14:59 AM
1. Assigned Priority Review Designation by Secretary of Defense under Law 115-92 which is used for military purposes. mrdc.health.mil/index.cfm/a...
2. In the latest Humacyte slide deck it says "Humacyte expects DOD to stockpile for deployment to sites of conflicts.
3. The Phase 2/3 clinical data included wartime injuries in both Ukraine, and Israel the two largest warzones right now.
4. In this article from 10/16/24 CEO Laura says the Department of Defense "Sponsored some of their trials". ncchamber.com/2024/10/16/du...
5. Received RMAT designation only given to products with an "unmet need" in the field fda.gov/vaccines-blood-biol....
6. The DOD gave them $1,000,000 Grant in 2017 Through the Medical Technology Enterprise Consortium (MTEC).
7. The DOD gave them $3,400,000 Contract Award through the BAA to support the Phase 2 studies. biospace.com/humacyte-award...
2. In the latest Humacyte slide deck it says "Humacyte expects DOD to stockpile for deployment to sites of conflicts.
3. The Phase 2/3 clinical data included wartime injuries in both Ukraine, and Israel the two largest warzones right now.
4. In this article from 10/16/24 CEO Laura says the Department of Defense "Sponsored some of their trials". ncchamber.com/2024/10/16/du...
5. Received RMAT designation only given to products with an "unmet need" in the field fda.gov/vaccines-blood-biol....
6. The DOD gave them $1,000,000 Grant in 2017 Through the Medical Technology Enterprise Consortium (MTEC).
7. The DOD gave them $3,400,000 Contract Award through the BAA to support the Phase 2 studies. biospace.com/humacyte-award...
(0)
(0)Humacyte, Inc. (HUMA) Stock Research Links
Scroll down for more posts ▼